Cargando…
Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715830/ https://www.ncbi.nlm.nih.gov/pubmed/34965010 http://dx.doi.org/10.1002/ctm2.647 |
_version_ | 1784624206013530112 |
---|---|
author | Qiu, Hangyuan Sun, Yaxun Pan, Ziwei Zhou, Jingjun Wang, Hongkun Wang, Xiaochen Cai, Dongsheng Fu, Guosheng Gong, Tingyu Jiang, Chenyang Liang, Ping |
author_facet | Qiu, Hangyuan Sun, Yaxun Pan, Ziwei Zhou, Jingjun Wang, Hongkun Wang, Xiaochen Cai, Dongsheng Fu, Guosheng Gong, Tingyu Jiang, Chenyang Liang, Ping |
author_sort | Qiu, Hangyuan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8715830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87158302022-01-06 Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation Qiu, Hangyuan Sun, Yaxun Pan, Ziwei Zhou, Jingjun Wang, Hongkun Wang, Xiaochen Cai, Dongsheng Fu, Guosheng Gong, Tingyu Jiang, Chenyang Liang, Ping Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-12-29 /pmc/articles/PMC8715830/ /pubmed/34965010 http://dx.doi.org/10.1002/ctm2.647 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Qiu, Hangyuan Sun, Yaxun Pan, Ziwei Zhou, Jingjun Wang, Hongkun Wang, Xiaochen Cai, Dongsheng Fu, Guosheng Gong, Tingyu Jiang, Chenyang Liang, Ping Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation |
title | Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation |
title_full | Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation |
title_fullStr | Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation |
title_full_unstemmed | Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation |
title_short | Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation |
title_sort | inhibition of hsc70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a mybpc3 mutation |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715830/ https://www.ncbi.nlm.nih.gov/pubmed/34965010 http://dx.doi.org/10.1002/ctm2.647 |
work_keys_str_mv | AT qiuhangyuan inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT sunyaxun inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT panziwei inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT zhoujingjun inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT wanghongkun inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT wangxiaochen inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT caidongsheng inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT fuguosheng inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT gongtingyu inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT jiangchenyang inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation AT liangping inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation |